Undiagnosed Chronic Kidney Disease, Outcomes, and Finerenone in Heart Failure

This secondary analysis of the FINEARTS-HF (Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients With Heart Failure) randomized clinical trial investigates the prevalence of undiagnosed chronic kidney disease in high-risk individuals with heart failure and its association with cardiovascular outcomes.

Corresponding Author: Muthiah Vaduganathan, MD, MPH, Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115 (mvaduganathan@bwh.harvard.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.